The α2-adrenoceptor antagonist atipamezole reduces the development and expression of D-amphetamine-induced behavioural sensitization

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 367, Issue 3, 2003, Pages 274-280

  Juhila, Juuso ^a,b   Haapalinna, Antti ^b   Sirviö, Jouni ^b   Sallinen, Jukka ^b   Honkanen, Aapo ^a   Korpi, Esa R ^a   Scheinin, Mika ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b ORION CORPORATION   (Finland)

Author keywords

2 adrenoceptors; Behavioural sensitization; D amphetamine; Locomotor activity

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; ATIPAMEZOLE; DEXAMPHETAMINE; IDAZOXAN; ALPHA 2 ADRENERGIC RECEPTOR; DOPAMINE; IMIDAZOLE DERIVATIVE;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; DRUG DEPENDENCE; DRUG EFFECT; DYSKINESIA; LOCOMOTION; MALE; MOUSE; NONHUMAN; SENSITIZATION; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG INTERACTION; METABOLISM; MOTOR ACTIVITY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BEHAVIOR, ANIMAL; DEXTROAMPHETAMINE; DOPAMINE; DRUG INTERACTIONS; IDAZOXAN; IMIDAZOLES; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 0037354574     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0695-6     Document Type: Article

References (41)

1. Archer T, Jonsson G, Ross SB (1985) Active and passive avoidance following the administration of systemic DSP4, xylamine, or p-chloroamphetamine. Behav Neural Biol 43:238-249
2. Archer T, Fredriksson A, Jonsson G, Lewander T, Mohammed AK, Ross SB, Soderberg U (1986) Central noradrenaline depletion antagonizes aspects of D-amphetamine-induced hyperactivity in the rat. Psychopharmacology 88:141-146
3. Barbeau A (1974) The clinical physiology of side effects in long-term L-DOPA therapy. Adv Neurol 5:347-365
4. Biegon A, Mathis CA, Budinger TF (1992) Quantitative in vitro and ex vivo autoradiography of the alpha 2-adrenoceptor antagonist [3H]atipamezole. Eur J Pharmacol 224:27-38
5. Blanc G, Trovero F, Vezina P, Herve D, Godeheu AM, Glowinski J, Tassin JP (1994) Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci 6:293-298
6. Brotchie JM (1998) Adjuncts to dopamine replacement: a pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease. Mov Disord 13:871-876
7. Bucheler MM, Hadamek K, Hein L (2002) Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), inhibit transmitter release in the brain of gene-targeted mice. Neuroscience 109:819-826
8. Cador M, Bjijou Y, Stinus L (1995) Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65:385-395
9. Cador M, Bjijou Y, Cailhol S, Stinus L (1999) D-amphetamine-induced behavioral sensitization: implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation. Neuroscience 94:705-721
10. Callado LF, Stamford JA (1999) Alpha2A- but not alpha2B/C-adrenoceptors modulate noradrenaline release in rat locus coeruleus: voltammetric data. Eur J Pharmacol 366:35-39
11. Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci 13:272-276
12. Dickinson SL, Gadie B, Tulloch IF (1988) Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by D-amphetamine and apomorphine in the rat. Psychopharmacology 96:521-527
13. Drouin C, Darracq L, Trovero F, Blanc G, Glowinski J, Cotecchia S, Tassin JP (2002) Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci 22:2873-2884
14. Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15:133-139
15. Grenhoff J, Nisell M, Ferre S, Aston-Jones G, Svensson TH (1993) Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J Neural Transm 93:11-25
16. Haapalinna A, Viitamaa T, MacDonald E, Savola JM, Tuomisto L, Virtanen R, Heinonen E (1997) Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine. Naunyn-Schmiedeberg's Arch Pharmacol 356:570-582
17. Haapalinna A, MacDonald E, Viitamaa T, Salonen JS, Sirvio J, Virtanen R (1999) Comparison of the effects of acute and sub-chronic administration of atipamezole on reaction to novelty and active avoidance learning in rats. Naunyn-Schmiedeberg's Arch Pharmacol 359:194-203
18. Henry B, Fox SH, Peggs D, Crossman AR, Brotchie JM (1999) The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-DOPA in the MPTP-lesioned primate model of Parkinson's disease. Mov Disord 14:744-753
19. Henry DJ, White FJ (1992) Electrophysiological correlates of psychomotor stimulant-induced sensitization. Ann NY Acad Sci 654:88-100
20. Jorm CM, Stamford JA (1993) Actions of the hypnotic anaesthetic, dexmedetomidine, on noradrenaline release and cell firing in rat locus coeruleus slices. Br J Anaesth 71:447-449
21. Lee A, Wissekerke AE, Rosin DL, Lynch KR (1998) Localization of alpha2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system. Neuroscience 84:1085-1096
22. Meana JJ, Callado LF, Pazos A, Grijalba B, Garcia-Sevilla JA (1996) The subtype-selective alpha 2-adrenoceptor antagonists BRL 44408 and ARC 239 also recognize 5-HT1A receptors in the rat brain. Eur J Pharmacol 312:385-388
23. Mohammed AK, Danysz W, Ogren SO, Archer T (1986) Central noradrenaline depletion attenuates amphetamine-induced locomotor behavior. Neurosci Lett 64:139-144
24. Newman-Tancredi A, Nicolas JP, Audinot V, Gavaudan S, Verriele L, Touzard M, Chaput C, Richard N, Millan MJ (1998) Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors. Naunyn-Schmiedebergs' Arch Pharmacol 358:197-206
25. Ogren SO, Archer T, Johansson C (1983) Evidence for a selective brain noradrenergic involvement in the locomotor stimulant effects of amphetamine in the rat. Neurosci Lett 43:327-331
26. Phillips TJ, Dickinson S, Burkhart-Kasch S (1994) Behavioral sensitization to drug stimulant effects in C57BL/6J and DBA/2J inbred mice. Behav Neurosci 108:789-803
27. Przegalinski E, Siwanowicz J, Baran L, Filip M (2000) Activation of serotonin (5-HT)1A receptors inhibits amphetamine sensitization in mice. Life Sci 66:1011-1019
28. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157-198
29. Sallinen J, Link RE, Haapalinna A, Viitamaa T, Kulatunga M, Sjoholm B, Macdonald E, Pelto-Huikko M, Leino T, Barsh GS, Kobilka BK, Scheinin M (1997) Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist. Mol Pharmacol 51:36-46
30. Sallinen J, Haapalinna A, Viitamaa T, Kobilka BK, Scheinin M (1998) D-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the alpha2C-adrenergic receptor subtype. Neuroscience 86:959-965
31. 2+ and its presynaptic alpha 2-adrenergic modulation. A study on the possible role of cyclic AMP. Naunyn Schmiedeberg's Arch Pharmacol 323:188-192
32. Sorg BA, Ulibarri C (1995) Application of a protein synthesis inhibitor into the ventral tegmental area, but not the nucleus accumbens, prevents behavioral sensitization to cocaine. Synapse 20:217-224
33. Trendelenburg AU, Limberger N, Starke K (1993) Presynaptic alpha 2-autoreceptors in brain cortex: alpha 2D in the rat and alpha 2A in the rabbit. Naunyn Schmiedeberg's Arch Pharmacol 348:35-45
34. Trendelenburg AU, Starke K, Limberger N (1994) Presynaptic alpha 2A-adrenoceptors inhibit the release of endogenous dopamine in rabbit caudate nucleus slices. Naunyn Schmiedeberg's Arch Pharmacol 350:473-481
35. Trendelenburg AU, Klebroff W, Hein L, Starke K (2001) A study of presynaptic alpha2-autoreceptors in alpha2A/D-, alpha2B- and alpha2C-adrenoceptor-deficient mice. Naunyn Schmiedeberg's Arch Pharmacol 364:117-130
36. Virtanen R, Savola JM, Saano V (1989) Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole. Arch Int Pharmacodyn Ther 297:190-204
37. Whittington RA, Virag L, Morishima HO, Vulliemoz Y (2001) Dexmedetomidine decreases extracellular dopamine concentrations in the rat nucleus accumbens. Brain Res 919:132-138
38. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492
39. Wolf ME, Dahlin SL, Hu XT, Xue CJ, White K (1995) Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists. Neuroscience 69:417-439
40. Yavich L, Lappalainen R, Sirvio J, Haapalinna A, MacDonald E (1997) Alpha2-adrenergic control of dopamine overflow and metabolism in mouse striatum. Eur J Pharmacol 339:113-119
41. Zhang K, Tarazi FI, Campbell A, Baldessarini RJ (2000) GABA(B) receptors: altered coupling to G-proteins in rats sensitized to amphetamine. Neuroscience 101:5-10